MolNFT v1 · #66485 · protein
The product template domain from pksa with palmitate bound
3HRQ · Aflatoxin biosynthesis polyketide synthase: “The product template domain from pksa with palmitate bound”. X-ray diffraction, 1 ligand (PLM), 4 pockets (best druggability 0.80). MolNFT v1 #66485 on GenesisL1: 3D structure, binding…
- PDB
- 3HRQ
- Type
- protein
- Length
- 636 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Aflatoxin biosynthesis polyketide synthase
- UniProt
- Q12053
- Ligands
- PLM
- Pockets
- 4 · best druggability 0.80
Structure
x-ray diffraction · 2 distinct chains · 28% helix, 40% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Aflatoxin biosynthesis polyketide synthase | protein | 317 | 29% helix, 40% strand | Q12053 |
| B | Aflatoxin biosynthesis polyketide synthase | protein | 319 | 27% helix, 40% strand | Q12053 |
Ligands and binding sites
- PLM · Palmitic acid · ligand · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 361 | 0.80 | 0.89 | 46 | PLM |
| 2 | 350 | 0.80 | 0.89 | 45 | PLM |
| 3 | 265 | 0.57 | 0.78 | 41 | empty |
| 4 | 117 | 0.46 | 0.79 | 24 | empty |
Interfaces
1 interface between chains.
- A–B · 1018 Ų buried · 26 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q12053
- Elsewhere: RCSB PDB 3HRQ · PDBe 3HRQ · UniProt Q12053
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.